Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07124741) titled 'Prognostic Power of the VEXUS Score in Septic Shock: Effectiveness in Mortality Prediction' on Aug. 8.

Study Type: Observational

Primary Sponsor: Antalya Training and Research Hospital

Condition: Septic Shock VExUS

Intervention: Diagnostic Test: Serial VEXUS Ultrasound Evaluation

Recruitment Status: Not recruiting

Date of First Enrollment: March 30, 2026

Target Sample Size: 100

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07124741

Published by HT Digital Content Services with permission from Health Daily Digest....